1. Allaudeen HS, Kozarich JW, Bertino JR, De Clercq E (1980) On the mechanism of selective inhibition of herpesvirus replication by (E)-5-(2-bromovinyl)-2?-deoxyuridine. In Proceedings of the International Conference on Human Herpesviruses, held at Emory University, Atlanta, Georgia, March 17?21
2. Binder PS (1977) Herpes simplex keratitis. Surv Ophthalmol 21:313
3. De Clercq E, Descamps J (1981, in press) On the mechanism of antiherpes action of E-5-(2-bromovinyl)-2?-deoxyuridine. In Proceedings of the International Symposium of the German Ophthalmologic Society on Herpetic Eye Diseases, held in Freiburg (im Breisgau), April 12?14, 1980. JF Bergmann Verlag, M�nchen
4. De Clerq E, Descamps J, Barr PJ, Jones AS, Serafinowski P, Walker RT, Huang G-F, Torrence PF, Schmidt CL, Mertes MP, Kulikowski T, Shugar D (1979a) Comparative study of the potency and selectivity of antiherpes compounds. In Skoda J, and Langen P (eds): Antimetabolites in Biochemistry, Biology and Medicine. Pergamon Press, Oxford and New York pp 275?285
5. De Clercq E, Descamps J, De Somer P, Barr PJ, Jones AS, Walker RT (1979b) (E)-5-(2-Bromovinyl)-2?-deoxyuridine: a potent and selective antiherpes agent. Proc Natl Acad Sci USA 76:2947